HIT vs MCAS
Histamine Intolerance and MCAS produce nearly identical symptoms. The difference is upstream — where the excess Histamine (and other mediators) is coming from.
The Fundamental Distinction
HIT is a plumbing problem. The faucet (mast cells) works normally. The drain (DAO, HNMT) is too small or partially blocked. Water (histamine) backs up.
MCAS is a faucet problem. The drain may work fine. But the faucet is stuck open — Mast Cells are producing and releasing mediators in excess.
Both together means the faucet is open AND the drain is clogged. This is common and makes everything harder to manage.
Why the Distinction Changes the Intervention
If you have HIT alone, the most impactful interventions target clearance:
- Low-histamine diet (reduce input)
- DAO Supplements (increase clearance)
- Avoid DAO inhibitors (alcohol, NSAIDs)
- Heal the gut to restore DAO production
- H1 Antihistamines and H2 Antihistamines for symptom relief
If you have MCAS alone, you need to calm the mast cells:
- Mast Cell Stabilizers like Cromolyn Sodium or Ketotifen (prevent Degranulation)
- H1 Antihistamines + H2 Antihistamines (block mediator receptors)
- Montelukast (block Leukotrienes)
- Trigger avoidance across the full range of Non-IgE Activation Pathways
- Stress reduction (The HPA Axis and Mast Cells)
- Hormonal management (Estrogen and Mast Cells)
If you have both, you need both strategies simultaneously — calm the source AND support clearance.
Diagnostic Differentiation
Looking at lab markers helps distinguish them:
| Marker | HIT | MCAS | Both |
|---|---|---|---|
| DAO Serum Levels | Low | Normal or low | Low |
| Serum Tryptase | Normal | May be elevated | May be elevated |
| Urine histamine metabolites | May be elevated | May be elevated | Likely elevated |
| Urine PGD2 metabolites | Normal | May be elevated | May be elevated |
| Response to low-histamine diet | Significant | Partial | Partial |
| Response to DAO Supplements | Helpful | Limited | Partially helpful |
| Response to Mast Cell Stabilizers | Limited | Significant | Significant |
The key distinguishing markers: if you see elevated prostaglandin or leukotriene metabolites, that points toward MCAS — those mediators come from mast cells, not from dietary intake. If you see low DAO with normal tryptase and prostaglandins, that points toward HIT.
Practical approach
In clinical practice, many providers start treatment empirically (low-histamine diet + antihistamines) and observe. If dietary intervention alone produces major improvement → leans toward HIT. If dietary intervention helps somewhat but significant symptoms persist → suggests MCAS component. If mast cell stabilizers produce additional improvement → confirms MCAS component. This iterative approach can be more informative than any single lab test.